The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2

Journal of Virology

Volumn 83, Issue 3, 2009, Pages 1538-1543

  Gammoh, Noor ^a   Gardiol, Daniela ^a,b   Massimi, Paola ^a   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b Instituto de Biologia Molecular y Celular de Rosario   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVITY; ENZYME REGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; VIRUS ACTIVATION; WART VIRUS;

HUMANS; PAPILLOMAVIRIDAE; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTION, GENETIC;

HUMAN PAPILLOMAVIRUS;

EID: 59749091943     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01551-08     Document Type: Article

References (31)

1. Adhikary, S., F. Marinoni, A. Hock, E. Hulleman, N. Popov, R. Beier, S. Bernard, M. Quarto, M. Capra, S. Goettig, U. Kogel, M. Scheffner, K. Helin, and M. Eilers. 2005. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123:409-421.
2. Brooks, C. L., and W. Gu. 2006. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21:307-315.
3. Calabro, V., G. Mansueto, T. Parisi, M. Vivo, R. A. Calogero, and G. La Mantia. 2002. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. J. Biol. Chem. 277:2674-2681.
4. Coutts, A. S., H. Boulahbel, A. Graham, and N. B. La Thangue. 2007. Mdm2 targets the p53 transcription cofactor JMY for degradation. EMBO Rep. 8:84-90.
5. Donaldson, M. M., W. Boner, and I. M. Morgan. 2007. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J. Virol. 81:4338-4342.
6. Gammoh, N., H. S. Grm, P. Massimi, and L. Banks. 2006. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator. J. Virol. 80:1787-1797.
7. Gonzalez, F., A. Delahodde, T. Kodadek, and S. A. Johnston. 2002. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296:548-550.
8. Grm, H. S., P. Massimi, N. Gammoh, and L. Banks. 2005. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene 24:5149-5164.
9. Iwakuma, T., and G. Lozano. 2003. MDM2, an introduction. Mol. Cancer Res. 1:993-1000.
10. Kassel, O., S. Schneider, C. Heilbock, M. Litfin, M. Gottlicher, and P. Herrlich. 2004. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters. Genes Dev. 18:2518-2528.
11. Kumar, R. A., S. R. Naidu, X. Wang, A. N. Imbalzano, and E. J. Androphy. 2007. Interaction of papillomavirus E2 protein with the Brm chromatin remodeling complex leads to enhanced transcriptional activation. J. Virol. 81:2213-2220.
12. Lee, D., H. Z. Kim, K. W. Jeong, Y. S. Shim, I. Horikawa, J. C. Barrett, and J. Choe. 2002. Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter. J. Biol. Chem. 277:27748- 27756.
13. Lim, J. H., Y. C. Chang, Y. B. Park, J. W. Park, and T. K. Kwon. 2004. Transcriptional repression of E2F gene by proteasome inhibitors in human osteosarcoma cells. Biochem. Biophys. Res. Commun. 318:868-872.
14. Lin, H. K., S. Altuwaijri, W. J. Lin, P. Y. Kan, L. L. Collins, and C. Chang. 2002. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J. Biol. Chem. 277:36570-36576.
15. Liu, X., H. Yuan, B. Fu, G. L. Disbrow, T. Apolinario, V. Tomaic, M. L. Kelley, C. C. Baker, J. Huibregtse, and R. Schlegel. 2005. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J. Biol. Chem. 280:10807-10816.
16. Mantovani, F., and L. Banks. 2003. Regulation of the discs large tumor suppressor by a phosphorylation-dependent interaction with the beta-TrCP ubiquitin ligase receptor. J. Biol. Chem. 278:42477-42486.
17. Massimi, P., D. Pim, C. Bertoli, V. Bouvard, and L. Banks. 1999. Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene 18:7748-7754.
18. McPhillips, M. G., J. G. Oliveira, J. E. Spindler, R. Mitra, and A. A. McBride. 2006. Brd4 is required for E2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 80:9530-9543.
19. Mohr, I. J., R. Clark, S. Sun, E. J. Androphy, P. MacPherson, and M. R. Botchan. 1990. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250:1694-1699.
20. Muratani, M., and W. P. Tansey. 2003. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4:192-201.
21. Perissi, V., A. Aggarwal, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-526.
22. Piccini, A., A. Storey, P. Massimi, and L. Banks. 1995. Mutations in the human papillomavirus type 16 E2 protein identify multiple regions of the protein involved in binding to E1. J. Gen. Virol. 76:2909-2913.
23. Reid, G., M. R. Hubner, R. Metivier, H. Brand, S. Denger, D. Manu, J. Beaudouin, J. Ellenberg, and F. Gannon. 2003. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11:695-707.
24. Rohlfs, M., S. Winkenbach, S. Meyer, T. Rupp, and M. Durst. 1991. Viral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16. Virology 183:331-342.
25. Saji, S., N. Okumura, H. Eguchi, S. Nakashima, A. Suzuki, M. Toi, Y. Nozawa, S. Saji, and S. Hayashi. 2001. MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells. Biochem. Biophys. Res. Commun. 281:259-265.
26. Salghetti, S. E., A. A. Caudy, J. G. Chenoweth, and W. P. Tansey. 2001. Regulation of transcriptional activation domain function by ubiquitin. Science 293:1651-1653.
27. Sang, B. C., and M. S. Barbosa. 1992. Increased E6/E7 transcription in HPV 18-immortalized human keratinocytes results from inactivation of E2 and additional cellular events. Virology 189:448-455.
28. Sdek, P., H. Ying, D. L. Chang, W. Qiu, H. Zheng, R. Touitou, M. J. Allday, and Z. X. Xiao. 2005. MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol. Cell 20:699-708.
29. Thain, A., K. Webster, D. Emery, A. R. Clarke, and K. Gaston. 1997. DNA binding and bending by the human papillomavirus type 16 E2 protein. Recognition of an extended binding site. J. Biol. Chem. 272:8236-8242.
30. Zheng, Z. M., and C. C. Baker. 2006. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 11:2286-2302.
31. Zhu, Q., G. Wani, J. Yao, S. Patnaik, Q. E. Wang, M. A. El-Mahdy, M. Praetorius-Ibba, and A. A. Wani. 2007. The ubiquitin-proteasome system regulates p53-mediated transcription at p21waf1 promoter. Oncogene 26:4199-4208.